Annual Drug Patent Expirations for ZERIT+XR
Zerit Xr is a drug marketed by Bristol Myers Squibb and is included in one NDA. There is one patent protecting this drug.
The generic ingredient in ZERIT XR is stavudine. Additional details are available on the stavudine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
